No photo of Kalpana Ghoshal

Kalpana Ghoshal

  • 198 Citations
  • 6 h-Index
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Kalpana Ghoshal is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
MicroRNAs Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Liver Neoplasms Medicine & Life Sciences
Liver Medicine & Life Sciences
Liver Diseases Medicine & Life Sciences
Untranslated RNA Medicine & Life Sciences
Transcriptome Medicine & Life Sciences
Glucosephosphate Dehydrogenase Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2016 2020

Research Output 2015 2018

  • 198 Citations
  • 6 h-Index
  • 7 Article
  • 1 Review article
6 Citations (Scopus)
Open Access
Hepatocellular Carcinoma
5 Citations (Scopus)

Reprograming of Glucose Metabolism by Zerumbone Suppresses Hepatocarcinogenesis

Wani, N. A., Zhang, B., Teng, K. Y., Barajas, J. M., Motiwala, T., Hu, P., Yu, L., Bruschweiler, R., Ghoshal, K. & Jacob, S. T., 1 Feb 2018, In : Molecular Cancer Research. 16, 2, p. 256-268 13 p.

Research output: Contribution to journalArticle

Open Access
Hepatocellular Carcinoma
Cell Cycle
9 Citations (Scopus)

The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer

Barajas, J. M., Reyes, R., Guerrero, M. J., Jacob, S. T., Motiwala, T. & Ghoshal, K., 1 Dec 2018, In : Scientific Reports. 8, 1, 9105.

Research output: Contribution to journalArticle

Open Access
Glucosephosphate Dehydrogenase
Liver Neoplasms
Hepatocellular Carcinoma
Pentose Phosphate Pathway
20 Citations (Scopus)

Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer

Luna, J. M., Barajas, J. M., Teng, K. Y., Sun, H. L., Moore, M. J., Rice, C. M., Darnell, R. B. & Ghoshal, K., 3 Aug 2017, In : Molecular Cell. 67, 3, p. 400-410.e7

Research output: Contribution to journalArticle

Open Access
Liver Neoplasms
Hepatocellular Carcinoma
24 Citations (Scopus)

Blocking the CCL2-CCR2 axis using CCL2-neutralizing antibody is an effective therapy for hepatocellular cancer in a mouse model

Teng, K. Y., Han, J., Zhang, X., Hsu, S. H., He, S., Wani, N. A., Barajas, J. M., Snyder, L. A., Frankel, W. L., Caligiuri, M. A., Jacob, S. T., Yu, J. & Ghoshal, K., Feb 2017, In : Molecular Cancer Therapeutics. 16, 2, p. 312-322 11 p.

Research output: Contribution to journalArticle

Open Access
Liver Neoplasms
Neutralizing Antibodies
Hepatocellular Carcinoma